PRPadmalatha S. Rai

Padmalatha S. Rai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Padmalatha S. Rai has a total of 128 co-authors. Here are the top co-authors by number of shared publications:

  • Kapaettu Satyamoorthy

    Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India

    16 shared publications
  • Chigateri M. Vinay

    Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India

    8 shared publications
  • Manik Vohra

    Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India

    8 shared publications
  • Navya B. Prabhu

    Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India

    6 shared publications
  • Anu Radha Sharma

    Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India

    5 shared publications
  • Bobby Paul

    Department of Bioinformatics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India

    5 shared publications

Latest Publications

  • Open Access

    A genomic approach for accurate identification and authentication of Alpinia galanga (L.) Willd. using SSH and NGS technologies

    by Kannath Udayamanoharan Sanjay, Manik Vohra, Anu Radha Sharma, Chigateri M Vinay, Debyani Samantray, Vidhu Sankar Babu, Yarappa Lakshmikanth Ramachandra, Bobby Paul, Padmalatha S Rai

    The authenticity of herbal products is a growing global concern due to frequent mislabeling, substitution, and adulteration, especially among high-value medicinal plants. Alpinia galanga (A.galanga) is widely used in traditional medicine to treat various ailments. However, it is frequently substituted with Alpinia calcarata (A.calcarata), which can compromise the safety and therapeutic efficacy of herbal formulations. Currently, no standardised method exists that is both rapid, sensitive, and cost-effective for distinguishing A. galanga from A. calcarata. Therefore, our study aimed to identify differential metabolites and employ suppression subtractive hybridisation (SSH) coupled with next-generation sequencing (NGS) in A. galanga and A. calcarata to develop species-specific DNA markers for the accurate authentication of A. galanga. The plant samples were collected and authenticated through taxonomic identification and DNA barcoding. Untargeted metabolite profiling was performed using UPLC–MS/MS. SSH, coupled with NGS, was used to develop species-specific markers, which were validated using PCR and Sanger sequencing. Taxonomic identification and DNA barcoding were successful, and the sequences were submitted to NCBI GenBank. A total of 152 metabolites were identified, and 50 significant differential metabolites were identified between A. galanga and A. calcarata, indicating chemical distinctions. The developed species-specific DNA markers demonstrated high sensitivity and specificity in distinguishing between the two species, and validation in commercial Rasna raw drug samples revealed adulteration. This study demonstrates the use of the SSH-NGS platform to develop species-specific DNA markers and provides a reliable tool for the authentication of A. galanga in both fresh plant materials and commercial products. Graphical Abstract

  • Open Access

    Elucidating the Molecular Mechanisms of Vitex negundo L. in Polycystic Ovary Syndrome via Metabolomics‐Driven Network Pharmacology

    by Nishmitha R. Poojary, Neeharika Narisepalli Venkatasai, Kannath U. Sanjay, Supraja M. Kodanch, Padmalatha S. Rai

    Polycystic ovary syndrome (PCOS) is a hormonal disorder marked by irregular menstrual cycles, elevated androgen levels, ovarian cysts, hirsutism, acne and other symptoms. While conventional medications such as Metformin and Spironolactone are commonly prescribed, they are often associated with undesirable side effects. As a result, there is growing interest in alternative treatments, particularly those involving medicinal plants. Vitex negundo L., a member of the Lamiaceae family, has demonstrated promising therapeutic effects against PCOS. However, its precise molecular mechanism of action remains unclear. To explore this, we conducted an untargeted metabolomics analysis using UPLC‐MS/MS to identify bioactive compounds, followed by network pharmacology to elucidate potential mechanisms. Metabolite fingerprinting revealed 186 metabolites, among which 122 were identified as secondary metabolites. Network pharmacology analysis uncovered 910 potential targets associated with the identified compounds and 297 known PCOS‐related disease targets, with 50 overlapping targets between the two datasets. Key hub targets identified included P53, ESR1, AKT1, STAT3, CTNNB1, ERBB2, BCL2, EGFR, MTOR and IL6. Furthermore, molecular docking highlighted several bioactive constituents—syringin, 4‐(3,4‐dihydroxyphenyl)‐6,7‐dihydroxynaphthalene‐2‐carboxylic acid, and Isovitexin—as potential lead compounds for PCOS treatment. Further evaluation of lead compounds can be conducted through in vitro and in vivo studies.

  • Open Access

    Bulk and single-cell multiomics insights into theca cell and granulosa cell dysfunction in polyendocrine metabolic ovarian syndrome

    by Supraja M. Kodanch, Vaishnavi Vyas, Saumya Bansal, Biligerepalya S. Chinmayi, Shashikala K. Bhat, Prashanth K. Adiga, Shama Prasada Kabekkodu, Padmalatha S. Rai

    Polyendocrine metabolic ovarian syndrome (PMOS) is a heterogeneous disorder marked by a variety of clinical, hormonal, and metabolic disorders of an endocrine nature, affecting women of reproductive age and causing anovulatory infertility, metabolic dysfunction and hormonal disorders of a heterogeneous nature. Because of its complicated etiology and varied clinical presentation, PMOS’s underlying processes are still poorly understood despite its high incidence. There is a growing body of literature that attributes the multifactorial nature of PMOS to genetic predisposition, epigenetic modifications, environmental variables, and metabolic abnormalities, which result in dysregulation of multiple cellular pathways associated with ovarian function. Ovarian theca and granulosa cells are crucial to the pathophysiology of PMOS because alterations in their activity result in aberrant steroidogenesis, follicular arrest, reduced oocyte development, and disrupted endocrine signalling. Recent advances in high-throughput multiomics technology have greatly advanced our understanding of the molecular landscape of PMOS. Recent advances in multiomics technologies, including genomics, epigenomics, transcriptomics, proteomics and metabolomics, have revolutionised our understanding of PMOS by allowing the integrated exploration of these molecular alterations. Genomic studies identified PMOS susceptibility loci, whereas epigenomic and transcriptomic studies revealed abnormal gene regulation and miRNA regulation. Proteomic and metabolomic profiling further elucidated functional disruption in protein networks and metabolic pathways, particularly in theca and granulosa cells. Bulk multiomics approaches have substantially advanced our understanding of PMOS through the identification of genetic, epigenetic, transcriptomic, proteomic, and metabolic alterations associated with disease pathogenesis. Cellular function and heterogeneity are largely governed by complex gene regulatory networks (GRNs) and dynamic cell-to-cell communication mechanisms. Recent advances in single-cell multiomics approaches have enabled the identification of cell-specific molecular signatures and improved the understanding of the complex interactions between ovarian cell populations. Integration of bulk and single-cell multiomics datasets offers a more nuanced perspective on disease mechanisms. By integrating multiomics data, the present review aims to provide a more detailed understanding of the PMOS, thereby facilitating the identification of clinically significant biomarkers, the clarification of key regulatory pathways, and the identification of potential treatment targets. Collectively, these findings provide a framework for future translational research to improve the diagnosis and management of PMOS.

  • Open Access

    From Soil To Solution: Metabolomic and Antimicrobial Insights into Acorus Calamus L. Root Systems

    by Andrew D’SOuza, Kannath U. Sanjay, Neeharika Narisepalli Venkatasai, Padmalatha S. Rai

    Acorus calamus L. ( A. calamus ) is a valuable medicinal plant traditionally used in Indian medicine for its therapeutic rhizomes. However, overharvesting has endangered natural populations, highlighting the need for alternative plant parts and sustainable cultivation methods. This study aimed to evaluate hydroponic cultivation as a sustainable strategy and to compare the metabolite and antibacterial profiles of hydroponically grown A. calamus roots with those of soil-grown rhizomes. Plants were cultivated using both hydroponic and soil-based systems. Growth performance was assessed, followed by LC-MS-based metabolomic profiling to identify key bioactive compounds. Network pharmacology analysis was used to predict antibacterial targets. The antibacterial activity of the root extracts was evaluated against Pseudomonas aeruginosa , Enterococcus faecalis , Staphylococcus aureus , and Streptococcus mutans. Hydroponically grown plants showed enhanced growth, including greater root biomass, compared to soil-grown plants. LC-MS analysis revealed higher concentrations of key bioactive metabolites, including allantoin, graveoline, and capnoidine, in hydroponic roots. Network pharmacology identified key antibacterial targets, including TLR4, TNF, BCL2, and HSP90AA1. Antibacterial assays demonstrated that hydroponic root extracts effectively inhibited the tested bacterial strains, with activity comparable to that of soil-grown roots. Our findings showed that hydroponic cultivation could effectively produce A. calamus roots with enhanced metabolite content and antibacterial efficacy. This approach offers a sustainable and effective method for utilising A. calamus roots as a reliable alternative for wild rhizomes.

  • Open Access

    CDMMM: a comprehensive platform of traditional Indian medicinal plant DNA barcodes and metabolite fingerprints database

    by Chigateri M. Vinay, Akshay Pramod Ware, Kannath U. Sanjay, Debyani Samantray, Reju R. Krishnan, Keyur Raval, Mahendran Sekar, Yarappa Lakshmikanth Ramachandra, Bobby Paul, Padmalatha S. Rai

    Herbal medicines, derived from medicinal plants, are in high demand due to global population growth and the increasing prevalence of chronic diseases; however, the use of substitutes or adulterants can compromise the quality of these medicines. DNA barcoding and metabolite fingerprinting are used to identify plants and ensure the safety of drugs. The effectiveness of authentication methods depends on the availability and coverage of the reference library. However, reference DNA barcodes and metabolite fingerprint libraries for traditional Indian medicinal plants are lacking, which hinders the authentication of herbal drugs and the elucidation of the therapeutic effects of secondary metabolites. In the present study, we developed a user-friendly ‘Comprehensive Database of Medicinal Plants, Molecular Markers, and Metabolite Fingerprinting (CDMMM)’ that provides extensive details on traditional Indian medicinal plants used in drug formulations, DNA barcode sequences, metabolites, and their therapeutic targets associated with diseases. CDMMM is an expandable data resource comprising 89 experimentally obtained DNA barcode accessions from 67 plant species, 3033 annotated plant metabolites, and 1414 therapeutic targets associated with 441 diseases from 20 plant species. The ever-expanding CDMMM resource is available at https://slsdb.manipal.edu/cdmmm/ . Overall, it is a powerful platform for taxonomy, systematics, species identification, and drug discovery, promoting knowledge and addressing taxonomic uncertainties.


  • Open Access

    High Salinity Induces Changes in the Leaf Transcriptome of Withania somnifera

    by Vittorio F. Nicolis, Hendrik W. Swiegers, N. Francois V. Burger, Rajiv Parshotam, Anandi Bierman, Padmalatha S. Rai, Annamalai Muthusamy, Anna-Maria Botha

    Withania somnifera , commonly referred to as Indian Ginseng, is a medicinally important plant that can be found in many regions of the world, such as South Africa and India. Withanolides are key secondary metabolites responsible for conferring the plant its unique medicinal properties. The reaction of W. somnifera to salt stress, in particular the possible effects on its withanolide production, has yet to be explored. Under salt stress, germination efficiency dropped by 17.8% and caused physiological damage to emerging roots. A transcriptome analysis of salt-stressed leaves revealed the differential regulation of 3048 transcripts, with gene ontology analysis indicating an increased transcript abundance associated with phenylpropanoid, plant hormone signaling, detoxification response, concomitant with reduced growth, energy metabolism, and protein modification. Most withanolide pathway genes were significantly downregulated. Notably, 26 transcription factor families, particularly AP2/ERF, NAC, GRAS, and HB-WOX members, as well as 10 Late Embryogenesis-Abundant members, predominantly dehydrins, were significantly differentially regulated, suggesting their potential involvement in the salt stress response of W. somnifera . This study provides valuable insights into the molecular responses of W. somnifera to salt stress, highlighting potential targets for future research and subsequently for withanolide production, which has vast potential in the pharmaceutical industry.


  • Phytochemical Screening and Docking-Based Evaluation of A. sclerocarpa Extracts Targeting 6OVA

    by Ash Wini, Prerana Pramod Dange, Pawar Sagar Namdeo, Y. R. Karthik, Padmalatha S. Rai, Y. L. Ramachandra

    Alphonsea sclerocarpa Thwaites, a member of the family Annonaceae, is a genus widely distributed across tropical regions. Traditionally, the whole plant of A. sclerocarpa has been valued for its significant therapeutic properties. The present study involved GC-MS analysis of plant extracts prepared using two different solvents: ethanol and petroleum ether. The ethanol extract identified 25 compounds, whereas the petroleum ether extract revealed 24 compounds. From each extract, four compounds were shortlisted for molecular docking studies against the target protein 6OVA.The binding energies of the ethanol-derived compounds were -1.8, -3.8, -1.9, and -1.5 kcal/mol, respectively. In contrast, the petroleum ether-derived compounds exhibited binding affinities of -1.1, -0.8, -1.6, and -2.0 kcal/mol. These results suggest that the compounds obtained from the ethanol extract have comparatively stronger binding affinities than those from the petroleum ether extract.

  • Open Access

    Analytical evaluation of C. pictus for its therapeutic properties and antioxidant activity in relation to anticancer potential against selected cancer cell lines

    by Ashwini, Y. L. Ramachandra, Pawar Sagar Namdeo, Prerana Pramod Dange, Padmalatha S. Rai

    Medicinal plants play an important role in medical care throughout history, including the modern period. Costus pictus, also known as the 'insulin plant,' exhibits numerous bioactivities, including anti-diabetic, antioxidant, anticancer, anti-inflammatory, and hepatoprotective properties. In the present investigation, C. pictus leaves were extracted using ethanol and petroleum ether, and GC-MS analysis revealed 26 and 24 chemical components, respectively. These compounds are used significantly in pharmacology. The antioxidant capabilities of medicinal plants have been studied since they may be in possession of a number of bioactive molecules. It has been demonstrated that antioxidants revert the development of cancer through micromanagement of tumours, and medicinal plants are a rich source of new and powerful antioxidants and anticancer bioactive molecules. In the present study, the anticancer potential of C. pictus leaf extracts in water, ethanol, and petroleum ether against MCF-7 cancer cell lines was evaluated. The MCF-7 cell line was inhibited by all three extracts in a dose-dependent manner. Key words: anti-cancer, anti-inflammatory, pharmacology, GC-MS, MCF-7 cancer cell lines,

  • Open Access

    Emerging trends in nucleic acid and peptide aptamers in plant science research

    by Kannath U. Sanjay, Chigateri M. Vinay, Navya B. Prabhu, Padmalatha S. Rai

    Main conclusion: Aptamer technology has significantly advanced the field of plant research, emerging as a tool for enhancing agricultural productivity, plant growth, and environmental monitoring. Aptamers are short nucleotide or amino acid sequences that can bind to a range of target molecules with high affinity and selectivity. In recent years, these affinity molecules have piqued the interest of researchers across various scientific fields, including pharmaceuticals, analytical chemistry, and plant science. Advancements in aptamer technology have significantly broadened the horizons of plant science, particularly in the areas of plant analyte detection, pathogen targeting, and protein function analysis. Despite the use of various other bioassays and molecular techniques for plant analyte detection, the small size, chemical stability, and cost-effective synthesis of aptamers make them invaluable tools for unravelling the complexities of plant cells. Here, we discuss the progress in the development of nucleic acid and peptide aptamers and summarize their applications in plant biotechnology. The principles and signalling methods of various aptamer-based biosensors and their prospects as biotechnological tools for functional genomic studies, pathogen resistance, and bioimaging are discussed. Finally, the present challenges and future perspectives of aptamer-based technology in plant research are also summarized.


  • Top Cited Papers
    Open Access

    A comprehensive review of factors affecting growth and secondary metabolites in hydroponically grown medicinal plants

    by Neeharika Narisepalli Venkatasai, Devija N. Shetty, Chigateri M. Vinay, Mahendran Sekar, Annamalai Muthusamy, Padmalatha S. Rai

    Main conclusion: Optimizing environmental factors can significantly increase the growth and secondary metabolite synthesis of hydroponically grown medicinal plants. This approach can help increase the quality and quantity of pharmacologically important metabolites to enhance therapeutic needs. Medicinal plants are key therapeutic sources for treating various ailments. The increasing demand for medicinal plants has resulted in the overharvesting of these plants in their natural habitat, which can lead to their extinction in the future. Soil-based cultivation faces challenges, such as a lack of arable land, drastic climatic changes, and attacks by soil-borne pathogens. To overcome these challenges, hydroponic cultivation, known as soilless cultivation, is a sustainable method. The yield and quality of medicinal plants depend on environmental factors, such as nutrients, pH, electrical conductivity, temperature, light, nanoparticles, phytohormones, and microorganisms. This article explores the impact of these environmental factors on the growth and secondary metabolite content of hydroponically grown medicinal plants. Our review reveals how environmental factors qualitatively and quantitatively influence the growth and secondary metabolites of medicinal plants grown in hydroponic systems and how these factors can be integrated into the enhancement of therapeutic compounds. Graphical